Carbacephem β-lactam antibiotics having chemical structures (I) and (II) are disclosed: including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar2, R1, R2 and R6 are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant Staphylococcus spp.
[EN] CARBACEPHEM ß-LACTAM ANTIBIOTICS<br/>[FR] ANTIBIOTIQUES BÊTA-LACTAMES À CARBACÉPHÈME
申请人:ACHAOGEN INC
公开号:WO2009055696A1
公开(公告)日:2009-04-30
Carbacephem β-lactam antibiotics having the following chemical structures (I) and (II) are disclosed, including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar2, R1, R2 and R3 are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant Staphylococcus spp.
[EN] CARBACEPHEM ß-LACTAM ANTIBIOTICS<br/>[FR] ANTIBIOTIQUES DE TYPE ?-LACTAME À BASE DE CARBACÉPHÈME
申请人:ACHAOGEN INC
公开号:WO2010030811A3
公开(公告)日:2010-08-12
CARBACEPHEM ß -LACTAM ANTIBIOTICS
申请人:Achaogen, Inc.
公开号:EP2205600A1
公开(公告)日:2010-07-14
CARBACEPHEM BETA-LACTAM ANTIBIOTICS
申请人:Wagman Allan S.
公开号:US20100267686A1
公开(公告)日:2010-10-21
Carbacephem β-lactam antibiotics having the following chemical structures (I) and (II) are disclosed:
including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar
2
, R
1
, R
2
and R
3
are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant
Staphylococcus
spp.